Liraglutide add-on to metformin improves postprandial glucose control compared with metformin monotherapy in patients with Type 2 diabetes: posthoc analysis of the Liraglutide Effe... by Stephens, J, Fulcher, G, Matthews, DR, Nauck, M, Svendsen, C, Donsmark, M, Garber, A

Long-term sustained glycaemic control with liraglutide and glimepiride (both plus metformin), with added benefits of weight loss and less hypoglycaemia with liraglutide: 2-year LEA... by Frid, A, Hermansen, K, Nauck, M, Shah, N, Tankova, T, Mitha, I, Zdravkovic, M, Matthews, D

Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)... by Nauck, M, Frid, A, Hermansen, K, Shah, N, Tankova, T, Mitha, I, Zdravkovic, M, Düring, M, Matthews, DR

Health-related quality of life in people with type 2 diabetes participating in the LEADER trial by Nauck, M, Buse, J, Mann, J, Pocock, S, Bosch-Traberg, H, Frimer-Larsen, H, Ye, Q, Gray, A

Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study by Nauck, M, Frid, A, Hermansen, K, Thomsen, AB, During, M, Shah, N, Tankova, T, Mitha, I, Matthews, D

Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes by Nauck, M, Frid, A, Hermansen, K, Shah, N, Tankova, T, Mitha, I, Zdravkovic, M, Düring, M, Matthews, DR

Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study. by Nauck, M, Frid, A, Hermansen, K, Thomsen, AB, During, M, Shah, N, Tankova, T, Mitha, I, Matthews, DR

Liraglutide, a once-daily human GLP-1 analogue, in type 2 diabetes provides similar glycaemic control with reduced body weight compared with glimepiride when added to metformin by Hermansen, K, Nauck, M, Frid, A, Shah, N, Tankova, T, Mitha, I, During, M, Zdravkovic, M, Matthews, D

Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a... by Jendle, J, Nauck, M, Matthews, DR, Frid, A, Hermansen, K, Düring, M, Zdravkovic, M, Strauss, B, Garber, A

The reduction of body weight with liraglutide, a once-daily human GLP-I analogue for type 2 diabetes, primarily comes from fat tissue and the fat tissue lost is predominantly visce... by Jendle, J, Nauck, M, Matthews, D, Frid, A, Hermansen, K, During, M, Zdravkovic, M, Strauss, B, Garber, A

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Stud... by Inzucchi, SE, Bergenstal, R, Buse, J, Diamant, M, Ferrannini, E, Nauck, M, Peters, A, Tsapas, A, Wender, R, Matthews, D

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Stu... by Inzucchi, SE, Bergenstal, R, Buse, J, Diamant, M, Ferrannini, E, Nauck, M, Peters, A, Tsapas, A, Wender, R, Matthews, D

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Stu... by Inzucchi, SE, Bergenstal, R, Buse, J, Diamant, M, Ferrannini, E, Nauck, M, Peters, A, Tsapas, A, Wender, R, Matthews, D

Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association... by Inzucchi, SE, Bergenstal, R, Buse, J, Diamant, M, Ferrannini, E, Nauck, M, Peters, A, Tsapas, A, Wender, R, Matthews, D

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Stu... by Inzucchi, SE, Bergenstal, R, Buse, J, Diamant, M, Ferrannini, E, Nauck, M, Peters, A, Tsapas, A, Wender, R, Matthews, DR

Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Stud... by Inzucchi, SE, Bergenstal, R, Buse, J, Diamant, M, Ferrannini, E, Nauck, M, Peters, A, Tsapas, A, Wender, R, Matthews, D

Increased Sphingosine-1-Phosphate Serum Concentrations in Subjects with Periodontitis: A Matter of Inflammation by Moritz E, Jedlitschky G, Negnal J, Tzvetkov MV, Daum G, Dörr M, Felix SB, Völzke H, Nauck M, Schwedhelm E, Meisel P, Kocher T, Rauch BH, Holtfreter B

Get full text

Rare genomic structural variants in complex disease: lessons from the replication of associations with obesity by Walters, R, Coin, L, Ruokonen, A, De Smith, A, El-Sayed Moustafa, J, Jacquemont, S, Elliott, P, Esko, T, Hartikainen, A, Laitinen, J, Männik, K, Martinet, D, Meyre, D, Nauck, M, Schurmann, C, Sladek, R, Thorleifsson, G, Thorsteinsdóttir, U, Valsesia, A, Waeber, G, Zufferey, F, Balkau, B, Pattou, F, Metspalu, A, Völzke, H, Vollenweider, P, Stefansson, K, Järvelin, MR, Beckmann, J, Froguel, P, Blakemore, A

Refining attention-deficit/hyperactivity disorder and autism spectrum disorder genetic loci by integrating summary data from genome-wide association, gene expression, and DNA methy... by Hammerschlag, AR, Byrne, EM, Agbessi, M, Ahsan, H, Alves, I, Andiappan, A, Arindrarto, W, Awadalla, P, Battle, A, Beutner, F, Bonder, MJ, Boomsma, DI, Christiansen, M, Claringbould, A, Deelen, P, Esko, T, Favé, MJ, Franke, L, Frayling, T, Gharib, SA, Gibson, G, Heijmans, BT, Hemani, G, Jansen, R, Kähönen, M, Kalnapenkis, A, Kasela, S, Kettunen, J, Kim, Y, Kirsten, H, Kovacs, P, Krohn, K, Kronberg-Guzman, J, Kukushkina, V, Kutalik, Z, Lee, B, Lehtimäki, T, Loeffler, M, Marigorta, UM, Mei, H, Milani, L, Montgomery, GW, Müller-Nurasyid, M, Nauck, M, Nivard, M, Penninx, B, Perola, M, Pervjakova, N, Pierce, BL, Powell, J, van Duijn, CM, Et al.

Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. by Kolz, M, Johnson, T, Sanna, S, Teumer, A, Vitart, V, Perola, M, Mangino, M, Albrecht, E, Wallace, C, Farrall, M, Johansson, A, Nyholt, DR, Aulchenko, Y, Beckmann, J, Bergmann, S, Bochud, M, Brown, M, Campbell, H, Connell, J, Dominiczak, A, Homuth, G, Lamina, C, McCarthy, M, Meitinger, T, Mooser, V, Munroe, P, Nauck, M, Peden, J, Prokisch, H, Salo, P, Salomaa, V, Samani, N, Schlessinger, D, Uda, M, Volker, U, Waeber, G, Waterworth, D, Wang-Sattler, R, Wright, A, Adamski, J, Whitfield, J, Gyllensten, U, Wilson, J, Rudan, I, Pramstaller, P, Watkins, H, Doering, A, Wichmann, H, Spector, T, Peltonen, L, Volzke, H, Nagaraja, R, Vollenweider, P, Caulfield, M, Illig, T, Gieger, C